Green‐Synthesised Nanoconjugates: Advancing Targeted Photodynamic Therapy for Lung Cancer
Chemistry & Biodiversity · 2025
DOI: 10.1002/cbdv.202501644 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Chemistry & Biodiversity, 2025. Verfasst von Njabulo Henry Sibanda und 2 weiteren Autor:innen. Beteiligte Einrichtung: Laser Research Centre, Faculty of Health Sciences, University of Johannesburg, Johannesburg, South Africa. Hauptthemen laut MEDLINE: Photochemotherapy, Lung Neoplasms, Photosensitizing Agents, Antineoplastic Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 129 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Research Foundation of South Africa Thuthuka Instrument, South African Medical Research Council, Department of Science and Innovation.
Abstract (Originalsprache)
Lung cancer is a type of cancer that develops around the airways or lungs and continues to be the leading cause of cancer‐related deaths worldwide. This has necessitated the need for innovative therapeutic strategies to overcome the limits of existing therapies such as surgery, chemotherapy and radiotherapy. Photodynamic therapy (PDT) has emerged as a promising non‐invasive treatment for lung cancer. This approach utilises photosensitisers (PSs) activated by light to generate reactive oxygen species (ROS), ultimately leading to cancer cell death. However, the effectiveness of PDT is often limited by several factors, including poor delivery of the PSs, low selectivity for cancer cells, and insufficient generation of ROS. This has created a need to further innovate therapeutic strategies to combat these shortfalls. Advancements in nanotechnology have introduced eco‐friendly or green‐synthesis methods by utilising plant extracts to produce silver nanoparticles (AgNPs). These have enhanced biocompatibility, reduced toxicity and can be used as effective carriers for PSs. Conjugating PS to green‐synthesised AgNPs improves drug stability, targeting capabilities, and overall therapeutic outcomes. Furthermore, AgNPs possess intrinsic plasmonic properties that enhance light absorption, thereby increasing ROS generation synergistically with PS activation. Despite all these advances, there remain several challenges, such as long‐term biosafety concerns and the scalability of green synthesis. This review discusses the synergistic potential of green‐synthesised AgNPs–PS conjugates in improving PDT for lung cancer via targeting lung cancer stem cells while examining their underlying mechanisms, recent preclinical and clinical advancements and future perspectives.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laser Research Centre, Faculty of Health Sciences, University of Johannesburg, Johannesburg, South Africa.
ORCID-Profile: Blassan P George
Förderung
- National Research Foundation of South Africa Thuthuka Instrument
- South African Medical Research Council
- Department of Science and Innovation
- University Research Council
- Department of Science and Technology's South African Research Chairs Initiative
- National Research Foundation of South Africa
- African Laser Centre, Council for Scientific and Industrial Research
Zitieren
APA
Sibanda, N. H., Crous, A., & George, B. P. (2025). Green‐Synthesised Nanoconjugates: Advancing Targeted Photodynamic Therapy for Lung Cancer. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202501644
Vancouver
Sibanda NH, Crous A, George BP. Green‐Synthesised Nanoconjugates: Advancing Targeted Photodynamic Therapy for Lung Cancer. Chemistry & Biodiversity. 2025. doi:10.1002/cbdv.202501644
BibTeX
@article{Sibanda2025,
author = {Sibanda, Njabulo Henry and Crous, Anine and George, Blassan P},
title = {Green‐Synthesised Nanoconjugates: Advancing Targeted Photodynamic Therapy for Lung Cancer},
journal = {Chemistry & Biodiversity},
year = {2025},
doi = {10.1002/cbdv.202501644}
}
EUVIMED